(Q44806881)

6 December 2017

title

17-Ketosteroid excretion, myasthenia, and cancer (English)

1 reference

6 December 2017

G A MacGregor

1

1 reference

6 December 2017

M J Levell

series ordinal

2

1 reference

6 December 2017

R B Payne

series ordinal

3

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 1972

1 reference

6 December 2017

1 reference

6 December 2017

volume

1

1 reference

6 December 2017

issue

7754

1 reference

6 December 2017

page(s)

790

1 reference

IMMUNOLOGICAL DISTURBANCES IN MYASTHENIA GRAVIS WITH A REPORT OF HASHIMOTO'S DISEASE DEVELOPING AFTER THYMECTOMY

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990539-9

7 January 2021

Sarcoidosis, thyroiditis, and Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990539-9

7 January 2021

Addison's disease, vitiligo and multiple autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990539-9

7 January 2021

The clinical value of urinary 17-ketogenic steroid determinations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990539-9

7 January 2021

A method for deriving normal ranges from laboratory specimens applied to uric acid in males

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990539-9

7 January 2021

Decreased Conversion of Androgens to Normal 17-Ketosteroid Metabolites: A Nonspecific Consequence of Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990539-9

7 January 2021

10.1016/S0140-6736(72)90539-9

Identifiers

DOI

1 reference

6 December 2017

1 reference